Problem
Clinical-trial data was scattered across CROs, labs, and country-specific repositories. Regulatory submissions took quarters and queries from regulators were frequent.
12 trials live on the platform. Data-prep time cut 71%. 3 regulators accepted submissions on first attempt.
Clinical-trial data was scattered across CROs, labs, and country-specific repositories. Regulatory submissions took quarters and queries from regulators were frequent.
Lakehouse with study-of-record semantic layer, data-quality contracts, and a standardised submission package generator. CRO data ingested via signed contracts.
Submission preparation time cut 36%. 12 trials live on the platform. Data-prep time cut 71%. 3 regulators accepted submissions on first attempt.
Five phases. One accountable team. Every phase had a named decision point and a measurable outcome.
Workshops with the Leading GCC Pharma Major executive team, baseline metrics, target outcome tree, programme governance set up.
Reference architecture, security blueprint, joint squad model agreed. Data model and integration contracts published.
Vertical slice built and run live-parallel against the existing system. Continuous integration, daily deploys, weekly business demos.
Phased cutover, audit-aligned reconciliation, scaling out of squads, capability transfer to Leading GCC Pharma Major teams.
Managed run with named SLOs, quarterly value reviews, and a 15% optimisation budget reserved for improvement work.
Cloud landing zone, identity, network, security baseline. Data fabric with lineage-by-default. Audit-grade observability stack from day one.
Domain-aligned microservices behind a published API surface. Event-driven core with CDC into the data fabric. Live-parallel capability built in, not bolted on.
RBAC, audit logs, lineage, policy-as-code. Model risk records for every production model. Compliance posture on the executive dashboard, not in a quarterly slide.
Production-grade choices, defended by track record. The stack is one engineering decision among many — but a load-bearing one.
Independent assurance reviews at each phase gate. Findings tracked in a single risk register with named owners and remediation deadlines.
ISO 27001, SOC 2 Type II controls applied throughout. Data lineage captured by default; sensitive data tokenised at the edge.
Every change tracked; every release reproducible. Audit packs assembled automatically for internal and external review.
Policy-as-code scans on every commit. Compliance posture surfaced on the executive dashboard, not in a quarterly report.
A submission cycle is no longer a war. It is a checklist.
V VP Clinical Operations · Leading GCC pharma major
14 months from kickoff to first regulated outcome — squad density and decision velocity matter more than headcount.
Joint squads with Leading GCC Pharma Major engineers stayed in place after go-live. Ownership did not transfer in a hand-off — it grew in place.
Live-parallel for a meaningful window before cutover bought us trust. The cutover itself was a flag flip, not a war room.
Tell us your sector and your timeline. A senior partner with sector experience will respond within one business day.